The Only Gold Stock You Need In 2020 - Free Report [sponsor]
This company's world-class gold discovery boosted its shares 118.9% in a single day and kicked off the biggest staking gold rush in the history of the region. Now the company is starting its biggest exploration drill program yet on the project and there's no telling where the stock could go next. But you have to get in early before it takes off. Get the exclusive details here.
Puerto Rico board approves $10B budget as resignations loom
Puerto Rico awoke to a new budget approved early Wednesday that largely suspends austerity measures and government cuts for one year as the U.S. territory struggles to recover from hurricanes, earthquakes and the pandemic. Read more >>
(ALERT) Google just poured $4 billion into THIS... [sponsor]
Companies all over the world are funneling as much money as they can into what Bill Gates calls, "the holy grail" of modern technology. It's fresh out of a highly secretive lab in Boston, and it's poised to make early investors billions. It's NOT cannabis. It's NOT bitcoin, or some other blockchain-related technology and it's NOT 5G. Click here for details.
Insurer Centene plans 3,200 jobs at new N.C. regional hub
Government health insurance provider Centene Corp. said on Wednesday it will build an East Coast campus in Charlotte, North Carolina, developing a $1 billion construction project that's expected to create more than 3,200 new jobs by 2032. Read more >>
Cannabis Comeback of 2020 - Buy Pre-IPO Shares for Just $0.25 [sponsor]
One tiny cannabis company is 100% LEGAL. It's getting ready to IPO within 90 days --- and you do NOT want to miss out. Grab your Pre-IPO shares right now - before the stock price surges. My report reveals why this stock could surge 733% when it goes public. Click here to get urgent details on this Pre-IPO.
Health experts slam US mass purchase of licensed virus drug
Public health experts on Wednesday criticized the U.S. for securing for itself a large supply of the only drug licensed so far to treat COVID-19. The U.S. government announced Monday that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to Americans during the next three months. Read more >>
DISCLAIMER: This communication includes advertising material and PAID ADVERTISEMENTS provided to our customers. Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. For full disclaimer information, click here.
Post a Comment
Post a Comment